Thomas M. Maier

1.1k total citations
30 papers, 929 citations indexed

About

Thomas M. Maier is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Thomas M. Maier has authored 30 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 12 papers in Molecular Biology and 11 papers in Inorganic Chemistry. Recurrent topics in Thomas M. Maier's work include Histone Deacetylase Inhibitors Research (8 papers), Synthesis and characterization of novel inorganic/organometallic compounds (6 papers) and Protein Degradation and Inhibitors (6 papers). Thomas M. Maier is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Synthesis and characterization of novel inorganic/organometallic compounds (6 papers) and Protein Degradation and Inhibitors (6 papers). Thomas M. Maier collaborates with scholars based in Germany, Netherlands and Slovakia. Thomas M. Maier's co-authors include Thomas Ciossek, Thomas Beckers, Robert Wolf, H. Wieland, Andreas Sellmer, Siavosh Mahboobi, Jan J. Weigand, Herwig Pongratz, Carmen Burkhardt and Emerich Eichhorn and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Biochemistry and ACS Catalysis.

In The Last Decade

Thomas M. Maier

30 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Maier Germany 17 517 421 265 195 54 30 929
J. Richard Morphy United States 16 486 0.9× 485 1.2× 176 0.7× 183 0.9× 90 1.7× 31 982
Mark Cornebise United States 11 203 0.4× 207 0.5× 120 0.5× 140 0.7× 47 0.9× 12 606
Tyler A. Davis United States 11 523 1.0× 359 0.9× 159 0.6× 79 0.4× 73 1.4× 17 904
Yuan‐Zheng Cheng China 24 2.0k 3.8× 198 0.5× 335 1.3× 80 0.4× 109 2.0× 50 2.4k
Ermal Ismalaj Belgium 15 527 1.0× 492 1.2× 296 1.1× 189 1.0× 41 0.8× 23 1.2k
Zhengtian Yu United States 16 231 0.4× 378 0.9× 66 0.2× 51 0.3× 56 1.0× 22 679
Natarajan Raju United States 19 324 0.6× 290 0.7× 71 0.3× 246 1.3× 169 3.1× 44 1.1k
Yantao Chen China 12 308 0.6× 258 0.6× 122 0.5× 23 0.1× 56 1.0× 28 605
Antonella Ciccarese Italy 16 361 0.7× 236 0.6× 159 0.6× 449 2.3× 93 1.7× 32 748
Douglas R. Cary Japan 15 344 0.7× 235 0.6× 208 0.8× 137 0.7× 236 4.4× 24 787

Countries citing papers authored by Thomas M. Maier

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Maier more than expected).

Fields of papers citing papers by Thomas M. Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Maier. The network helps show where Thomas M. Maier may publish in the future.

Co-authorship network of co-authors of Thomas M. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Maier. A scholar is included among the top collaborators of Thomas M. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Maier. Thomas M. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hierlmeier, Gabriele, Peter Coburger, Daniel J. Scott, et al.. (2021). Di‐tert‐butyldiphosphatetrahedrane as a Source of 1,2‐Diphosphacyclobutadiene Ligands. Chemistry - A European Journal. 27(60). 14936–14946. 11 indexed citations
2.
Maier, Thomas M., et al.. (2020). Heterogeneous Olefin Hydrogenation Enabled by a Highly‐Reduced Nickel(−II) Catalyst Precursor. Chemistry - A European Journal. 26(28). 6113–6117. 16 indexed citations
3.
Maier, Thomas M., et al.. (2019). [3+2] Fragmentation of a Pentaphosphido Ligand by Cyanide. Angewandte Chemie International Edition. 58(52). 18931–18936. 40 indexed citations
4.
Maier, Thomas M., Peter Coburger, Nicolaas P. van Leest, Evamarie Hey‐Hawkins, & Robert Wolf. (2019). Direct synthesis of an anionic 13-vertex closo-cobaltacarborane cluster. Dalton Transactions. 48(42). 15772–15777. 5 indexed citations
5.
Maier, Thomas M., et al.. (2018). Construction of alkyl-substituted pentaphosphido ligands in the coordination sphere of cobalt. Chemical Science. 10(5). 1302–1308. 36 indexed citations
6.
Maier, Thomas M., et al.. (2018). Amine‐Borane Dehydrogenation and Transfer Hydrogenation Catalyzed by α‐Diimine Cobaltates. Chemistry - A European Journal. 25(1). 238–245. 69 indexed citations
7.
Maier, Thomas M., Dirk Herrmann, Bas de Bruin, et al.. (2016). Selective P4 Activation by a Highly Reduced Cobaltate: Synthesis of Dicobalt Tetraphosphido Complexes. Chemistry - A European Journal. 23(25). 6094–6102. 54 indexed citations
8.
Bürkle, Alexander, et al.. (2011). Cell cycle‐dependent cytotoxicity and mitotic spindle checkpoint dependency of investigational and approved antimitotic agents. International Journal of Cancer. 130(4). 798–807. 7 indexed citations
10.
Mahboobi, Siavosh, Stefan Dove, Andreas Sellmer, et al.. (2009). Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases. Journal of Medicinal Chemistry. 52(8). 2265–2279. 80 indexed citations
11.
Dehmel, Florian, Thomas Ciossek, Thomas M. Maier, et al.. (2008). Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles. Journal of Medicinal Chemistry. 51(13). 3985–4001. 33 indexed citations
12.
Ciossek, Thomas, et al.. (2007). A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening. Analytical Biochemistry. 372(1). 72–81. 32 indexed citations
13.
Dehmel, Florian, Thomas Ciossek, Thomas M. Maier, et al.. (2007). Trithiocarbonates—Exploration of a new head group for HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4746–4752. 33 indexed citations
14.
Mahboobi, Siavosh, Andreas Sellmer, Emerich Eichhorn, et al.. (2006). [4-(Imidazol-1-yl)thiazol-2-yl]phenylamines. A Novel Class of Highly Potent Colchicine Site Binding Tubulin Inhibitors: Synthesis and Cytotoxic Activity on Selected Human Cancer Cell Lines. Journal of Medicinal Chemistry. 49(19). 5769–5776. 24 indexed citations
15.
Maier, Thomas M. & Friedrich Cavagna. (1982). 3‐Hydroxy‐2‐(1,2,4‐triazol‐1‐yl)acrylsäure‐ethylester und O‐funktionelle Derivate. Angewandte Chemie. 94(7). 549–549. 13 indexed citations
16.
Kantlehner, Willi, et al.. (1982). Ein einfaches Verfahren zur Herstellung vonN,N-Dialkyl-2,2,2-trialkoxyacetamidinen. Synthesis. 1982(4). 276–277. 2 indexed citations
17.
Kantlehner, Willi, et al.. (1981). Ein neues ergiebiges Verfahren zur Herstellung von Trialkyl-orthobenzoaten und Trialkyl-orthophenylpropynoaten. Synthesis. 1981(5). 380–381. 10 indexed citations
18.
Maier, Thomas M., et al.. (1980). β-Azolyl-α,α-dicarbonylverbindungen. Angewandte Chemie. 92(2). 128–129. 5 indexed citations
19.
Maier, Thomas M., et al.. (1980). β‐Azolyl‐α,α‐dicarbonyl Compounds. Angewandte Chemie International Edition in English. 19(2). 137–138. 6 indexed citations
20.
Kantlehner, Willi, et al.. (1979). Tris-[dialkylamino]-methane und Tetraalkylformamidinium-thiocyanate aus Bis-[dialkylamino]-acetonitrilen. Synthesis. 1979(5). 342–343. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026